SHADI SAYEGH: Open Payments
NPI 1316351174 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 56 payments from 18 companies in 2025. Trend: 2023 $1,230 · 2024 $1,234 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $426 |
| ABBVIE INC. | 6 | $164 |
| Xeris Pharmaceuticals, Inc. | 1 | $131 |
| Amgen Inc. | 1 | $124 |
| Sumitomo Pharma America, Inc. | 4 | $104 |
| Ardelyx, Inc. | 3 | $79 |
| Exact Sciences Corporation | 3 | $76 |
| Lilly USA, LLC | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
Products named: Rybelsus, Ozempic, RECORLEV, REPATHA, UBRELVY, GEMTESA, JARDIANCE, IBSRELA.
Industry payments across NY — which companies pay providers there.
